Related Experiment Video
Updated: Mar 8, 2026
07:25
Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
Published on: March 1, 2024
3.1K
[Glioblastoma, innovations in surgery]
Thiebaud Picart1, Jacques Guyotat1
1Service de neurochirurgie oncologique et vasculaire, hôpital neurologique Pierre Wertheimer, CHU de Lyon, 59 Boulevard Pinel, 69500 Bron, France.
Revue De L'Infirmiere
|February 6, 2017
Summary
Glioblastoma surgery uses 5-aminolevulinic acid (5-ALA) to make tumors fluorescent. This fluorescence, from protoporphyrine IX (PPIX), aids visualization during surgical procedures.
Area of Science:
- Oncology
- Surgical Innovation
- Biochemistry
Background:
- Glioblastoma surgery requires precise tumor visualization.
- Current visualization methods can be challenging.
Purpose of the Study:
- To describe the principle of using 5-aminolevulinic acid (5-ALA) for intraoperative glioblastoma visualization.
- To explain the biochemical mechanism behind 5-ALA-induced fluorescence.
Main Methods:
- Administration of 5-aminolevulinic acid (5-ALA) prior to surgery.
- Utilizing blue light stimulation to induce fluorescence.
- Visualizing the tumor via the emitted red light from protoporphyrine IX (PPIX).
Main Results:
- 5-aminolevulinic acid (5-ALA) is enzymatically converted to protoporphyrine IX (PPIX).
- Protoporphyrine IX (PPIX) exhibits red fluorescence when exposed to blue light.
- This fluorescence enhances the visibility of glioblastoma tissue.
Conclusions:
- 5-ALA is an effective agent for intraoperative glioblastoma visualization.
- The fluorescence of PPIX aids surgeons in differentiating tumor margins.
- This technique represents an innovative principle in glioblastoma surgery.
